102 related articles for article (PubMed ID: 11860274)
1. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
[TBL] [Abstract][Full Text] [Related]
2. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
3. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway.
González de Aguilar JL; Gordon JW; René F; de Tapia M; Lutz-Bucher B; Gaiddon C; Loeffler JP
Neurobiol Dis; 2000 Aug; 7(4):406-15. PubMed ID: 10964611
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
[TBL] [Abstract][Full Text] [Related]
6. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
7. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial alterations in transgenic mice with an H46R mutant Cu/Zn superoxide dismutase gene.
Sasaki S; Aoki M; Nagai M; Kobayashi M; Itoyama Y
J Neuropathol Exp Neurol; 2009 Apr; 68(4):365-73. PubMed ID: 19287315
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed mutant G93A superoxide dismutase protects calcineurin from inactivation.
Li S; Wang X; Klee CB; Krieger C
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):156-61. PubMed ID: 15193434
[TBL] [Abstract][Full Text] [Related]
10. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
Aoki M
Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
[TBL] [Abstract][Full Text] [Related]
11. ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury.
Guo Z; Kindy MS; Kruman I; Mattson MP
J Cereb Blood Flow Metab; 2000 Mar; 20(3):463-8. PubMed ID: 10724110
[TBL] [Abstract][Full Text] [Related]
12. Early and selective pathology of light chain neurofilament in the spinal cord and sciatic nerve of G86R mutant superoxide dismutase transgenic mice.
Morrison BM; Shu IW; Wilcox AL; Gordon JW; Morrison JH
Exp Neurol; 2000 Oct; 165(2):207-20. PubMed ID: 10993681
[TBL] [Abstract][Full Text] [Related]
13. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
McCord JM
Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
[No Abstract] [Full Text] [Related]
14. [Molecular mechanism of ALS and a possible gene therapy].
Abe K; Warita H
Rinsho Shinkeigaku; 1999 Jan; 39(1):68-9. PubMed ID: 10377808
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial defects in transgenic mice expressing Cu,Zn superoxide dismutase mutations: the role of copper chaperone for SOD1.
Son M; Elliott JL
J Neurol Sci; 2014 Jan; 336(1-2):1-7. PubMed ID: 24269091
[TBL] [Abstract][Full Text] [Related]
16. Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons.
Dupuis L; de Tapia M; René F; Lutz-Bucher B; Gordon JW; Mercken L; Pradier L; Loeffler JP
Neurobiol Dis; 2000 Aug; 7(4):274-85. PubMed ID: 10964600
[TBL] [Abstract][Full Text] [Related]
17. Light-induced retinal damage in mice carrying a mutated SOD I gene.
Mittag TW; Bayer AU; La VAIL MM
Exp Eye Res; 1999 Dec; 69(6):677-83. PubMed ID: 10620397
[TBL] [Abstract][Full Text] [Related]
18. Early decrease of the immunophilin FKBP 52 in the spinal cord of a transgenic model for amyotrophic lateral sclerosis.
Manabe Y; Warita H; Murakami T; Shiote M; Hayashi T; Omori N; Nagano I; Shoji M; Abe K
Brain Res; 2002 May; 935(1-2):124-8. PubMed ID: 12062482
[TBL] [Abstract][Full Text] [Related]
19. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
Gurney ME; Cutting FB; Zhai P; Doble A; Taylor CP; Andrus PK; Hall ED
Ann Neurol; 1996 Feb; 39(2):147-57. PubMed ID: 8967745
[TBL] [Abstract][Full Text] [Related]
20. Normal prion protein has an activity like that of superoxide dismutase.
Brown DR; Wong BS; Hafiz F; Clive C; Haswell SJ; Jones IM
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):1-5. PubMed ID: 10548526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
